Grantham, Mayo, Van Otterloo & Co (GMO)
OFIX icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Orthofix Medical OFIX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,900
Closed -$699K – 598
2018
Q1 		$699K Buy
11,900
+5,200
+78% +$291K ﹤0.01% 418
2017
Q4 		$366K Buy
+6,700
New +$347K ﹤0.01% 490

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s OFIX Position: Q2 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Orthofix Medical (OFIX) in Q2 2018, closing a stake of 11,900 shares — an estimated $699K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in OFIX in Q4 2017 and held it in 2 quarters. The position peaked at $699K in Q1 2018. 163 funds tracked by Wall St. Rank hold OFIX as of Q2 2018.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Orthofix Medical position as of Q2 2018 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,900 Orthofix Medical shares in Q2 2018, an estimated $699K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Orthofix Medical in Q4 2017 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Orthofix Medical position peaked at $699K in Q1 2018.
  • 163 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2018, filed 14 Aug 2018.